Publication | Open Access

Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial

OncologyGastrointestinal OncologyMedicineFirst-line TreatmentSurgeryPharmacotherapyMetastatic Gastric CancerCancer TreatmentPharmacologyRadiation Oncology